Market exclusivity for biologics. 2010

Allan Pollock, and Martin Zagari

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068817 Epoetin Alfa A recombinant glycosylated form of erythropoietin which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients. Binocrit,Epoetin Alfa Hexal,Epogen,Eprex,HX575,HX575 Compound,Heberitro,Procrit,Recombinant 1-165 Erythropoietin, Glycoform Alpha,Alfa Hexal, Epoetin,Alfa, Epoetin,Compound, HX575,Hexal, Epoetin Alfa,Recombinant 1 165 Erythropoietin, Glycoform Alpha
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.

Related Publications

Allan Pollock, and Martin Zagari
February 2010, The New England journal of medicine,
Allan Pollock, and Martin Zagari
December 2010, The New England journal of medicine,
Allan Pollock, and Martin Zagari
November 2009, The New England journal of medicine,
Allan Pollock, and Martin Zagari
January 2011, Nature reviews. Drug discovery,
Allan Pollock, and Martin Zagari
August 2009, Nature biotechnology,
Allan Pollock, and Martin Zagari
March 2011, Future medicinal chemistry,
Allan Pollock, and Martin Zagari
November 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research,
Allan Pollock, and Martin Zagari
April 2011, Health affairs (Project Hope),
Allan Pollock, and Martin Zagari
July 2011, Nature reviews. Drug discovery,
Allan Pollock, and Martin Zagari
January 2000, Food and drug law journal,
Copied contents to your clipboard!